Screener
Amneal Pharmaceuticals, Inc. AMRX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s net margin?
- Amneal Pharmaceuticals, Inc. (AMRX) reported net margin of 5% in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s net margin changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s net margin increased by 4166.9% year-over-year, from 0.1% to 5%.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s net margin?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s net margin has grown at a -40.8% compound annual growth rate (CAGR), from -11.5% to 2.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Amneal Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude